Search results for abx831340

Bermekimab, Abbexa, abx831340

Bermekimab is a monoclonal antibody biosimilar expressed in CHO cells, targeting IL1A, for use in laboratory research applications. This product is not suitable for use as medicines or in human, therapeutic or diagnostic applications. Bermekimab is under investigation in clinical trial NCT01384630 (Safety, Pharmacokinetics, and Efficacy of RA-18C3 in Subjects With Moderate to Severe Psoriasis).